Sindrome de Cushing iatrogénico por corticoides inhalados en paciente VIH

Autores/as

  • Alondra Frías
  • Alex Ortiz
  • Miriam Soto
  • Francisco Muñoz
  • Carolina Chacón

Palabras clave:

Cushing syndrome, Fluticasone, HIV, Ritonavir

Resumen

We report a 41 years old man with HIV and a chronic obstructive pulmonary disease, treated for seven months with Fluticasone/ Salmeterol and antiretroviral therapy (Lamivudine, Tenofovir, Atazanavir and Ritonavir). While using these medications, the patients developed a Cushing syndrome in a period of five months. After performing laboratory and imaging tests, it was concluded that the most probable cause of the syndrome was the interaction of inhaled steroids with Ritonavir. After discontinuing these medications the syndrome reverted in a period of 8 months.

Descargas

Publicado

2016-05-26

Cómo citar

Frías, A., Ortiz, A., Soto, M., Muñoz, F., & Chacón, C. (2016). Sindrome de Cushing iatrogénico por corticoides inhalados en paciente VIH. Revista Médica De Chile, 144(7). Recuperado a partir de https://mail.revistamedicadechile.cl/index.php/rmedica/article/view/4728

Número

Sección

Reporte de Caso Clínico

Artículos más leídos del mismo autor/a